HIV bone loss mystery: new study probes antiretroviral link
NCT ID NCT00146094
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 33 times
Summary
This study looked at bone density changes in HIV-positive men over two years. Researchers compared those starting antiretroviral therapy with those not on treatment to see if the drugs affect bone health. The goal was to better understand why HIV patients may have higher rates of bone thinning and osteoporosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Hospitalier de Colmar
Colmar, 68021, France
-
Centre Hospitalier de Mulhouse
Mulhouse, 68070, France
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.